RxDoctor Payments Data

Leonardo de Castro Duraes, MD

Colon & Rectal Surgery · Cleveland, OHNPI 1720515968

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (40.1%), education and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Intuitive Surgical at 48.2% of the total. Reporting peaked in 2020 at $2,988 and has fallen 82.5% since, to $522 in 2025.

$5,943in general payments, 2019–2025

Across 28 payments — averaging $212.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$3K
  • THD America, Inc.$747
  • Medtronic$585
  • Aroa Biosurgery Incorporated$567
  • Kerecis Limited$384
  • Avita Medical Americas, LLC$149
  • plus $646 from 7 others

What the payments were for

  • Travel & lodging$1,55826%
  • Food & beverage$2,38440%
  • Education$2,00034%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,943 in reported general payments places this provider in the 75th percentile of 101 colon & rectal surgery providers in Ohio.

See all colon & rectal surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$88,390
Medicare patients
166
Services billed
460

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Neomycin Sulfate13$47
Metronidazole11$12

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →